Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: United Kingdom Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20041
20052
20062
20071
20082
20101
20121
20134
20142
20162
20173
20182
20192
20201
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated5
Recruiting2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi7
Boehringer Ingelheim3
Daiichi Sankyo3
Bayer2
Bristol-Myers Squibb2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Janssen Scientific Affairs, LLC2
University of Surrey2
Anthos Therapeutics, Inc.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation36
Stroke8
Arrhythmias, Cardiac6
Atrial Flutter5
Cardiovascular Diseases2
Embolism2
Hemorrhage2
Intracranial Hemorrhages2
Acute Coronary Syndrome1
Anemia1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.